Deepak L. Bhatt
Stanford University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Deepak L. Bhatt.
Journal of the American College of Cardiology | 2016
Selvaraj S; Deepak L. Bhatt; Gregg W. Stone; Gibson Cm; Ph. Gabriel Steg; Christian W. Hamm; Matthew J. Price; Efthymios N. Deliargyris; Jayne Prats; Kenneth W. Mahaffey; Harvey D. White; Robert A. Harrington; Champion Phoenix Investigators
Timely percutaneous coronary intervention (PCI) in ST-segment elevation myocardial infarction (STEMI) is a cornerstone of therapy. Several analyses have demonstrated worse outcomes for patients presenting with STEMI during off-hours compared with during the workday [(1)][1]. The etiology of this
Journal of the American College of Cardiology | 2018
Christoph Olivier; Freddy Abnousi; Vandana Sundaram; Jaden Yang; Gregg W. Stone; Philippe Gabriel Steg; C. Michael Gibson; Christian Hamm; Matthew J. Price; Efthymios N. Deliargyris; Jayne Prats; Harvey D. White; Robert A. Harrington; Deepak L. Bhatt; Kenneth W. Mahaffey; Celina M. Yong; Champion Phoenix Investigators
The intravenous, rapidly acting P2Y12 inhibitor cangrelor reduces the rate of ischemic events during percutaneous coronary intervention (PCI) with no significant increase in severe bleeding. This study aimed to evaluate the efficacy and safety of cangrelor in patients treated with single vessel (SV
Journal of the American College of Cardiology | 2016
Muthiah Vaduganathan; Robert A. Harrington; Gregg W. Stone; Philippe Gabriel Steg; C. Michael Gibson; Christian Hamm; Matthew J. Price; Alberto Menozzi; Jayne Prats; Efthymios N. Deliargyris; Kenneth W. Mahaffey; Harvey D. White; Deepak L. Bhatt
Cangrelor, an intravenous, reversible P2Y12 antagonist, was recently approved for use in patients undergoing percutaneous coronary intervention (PCI) in the US. We evaluated the efficacy and safety of cangrelor compared with clopidogrel in the subgroup who received glycoprotein IIb/IIIa inhibitors
Archive | 2017
Lakshmi Venkitachalam; Kaijun Wang; Avi Porath; Ramón Corbalán; Alan T. Hirsch; David J. Cohen; Sidney C. Smith; E. Magnus Ohman; Deepak L. Bhatt; Elizabeth A. Magnuson; Hôpital Bichat
Journal of the American College of Cardiology | 2017
Christoph Olivier; Vandana Sundaram; Victoria Y. Ding; Lingyao Yang; Sergio Leonardi; Renato Lopes; Deepak L. Bhatt; Gregg W. Stone; Philippe Gabriel Steg; C. Michael Gibson; Christian Hamm; Matthew J. Price; Harvey D. White; Manisha Desai; Robert A. Harrington; Donald R. Lynch; Kenneth W. Mahaffey
Archive | 2014
W. Keith Hoots; Yves Rosenberg; Matthew J. Price; David J. Schneider; Daniel I. Simon; Jeffrey I. Weitz; S Marlene; Jean-Sébastien Hulot; Kenneth G. Mann; Jessica L. Mega; Kiran Musunuru; J. Angiolillo; Eric R. Bates; David J. Cohen; Barry S. Coller; Bruce Furie; Valentin Fuster; Deepak L. Bhatt; Robert M. Califf; Alan D. Michelson; Marc S. Sabatine
Archive | 2014
WilliamB . White; John D. Bisognano; David A. Calhoun; Raymond R. Townsend; Herbert D. Aronow; Deepak L. Bhatt; George L. Bakris
Archive | 2013
Eric J. Topol; Khaled M. Ziada; Katherine E. Wolski; David J. Moliterno; Sorin J. Brener; Stephen G. Ellis; Fernando Cura; Deepak L. Bhatt; A. Michael Lincoff; Samir R. Kapadia
Archive | 2012
Philip R. Schauer; Sangeeta R. Kashyap; Kathy Wolski; Stacy A. Brethauer; John P. Kirwan; Susan Thomas; Beth Abood; Steven E. Nissen; Deepak L. Bhatt
Archive | 2011
Vidyasagar Kalahasti; Derek P. Chew; Ryan Zuzek; Stephen G. Ellis; Deepak L. Bhatt
